GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merus Labs International Inc (NAS:MSLI) » Definitions » Asset Turnover

Merus Labs International (Merus Labs International) Asset Turnover : 0.06 (As of Mar. 2017)


View and export this data going back to 1996. Start your Free Trial

What is Merus Labs International Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Merus Labs International's Revenue for the three months ended in Mar. 2017 was $16.92 Mil. Merus Labs International's Total Assets for the quarter that ended in Mar. 2017 was $265.82 Mil. Therefore, Merus Labs International's Asset Turnover for the quarter that ended in Mar. 2017 was 0.06.

Asset Turnover is linked to ROE % through Du Pont Formula. Merus Labs International's annualized ROE % for the quarter that ended in Mar. 2017 was -2.49%. It is also linked to ROA % through Du Pont Formula. Merus Labs International's annualized ROA % for the quarter that ended in Mar. 2017 was -1.32%.


Merus Labs International Asset Turnover Historical Data

The historical data trend for Merus Labs International's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merus Labs International Asset Turnover Chart

Merus Labs International Annual Data
Trend Sep07 Sep08 Sep09 Sep10 Sep11 Sep12 Sep13 Sep14 Sep15 Sep16
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.18 0.31 0.18 0.20 0.29

Merus Labs International Quarterly Data
Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.07 0.08 0.07 0.06

Competitive Comparison of Merus Labs International's Asset Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Merus Labs International's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merus Labs International's Asset Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merus Labs International's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Merus Labs International's Asset Turnover falls into.



Merus Labs International Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Merus Labs International's Asset Turnover for the fiscal year that ended in Sep. 2016 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Sep. 2016 )/( (Total Assets (A: Sep. 2015 )+Total Assets (A: Sep. 2016 ))/ count )
=69.481/( (198.993+286.379)/ 2 )
=69.481/242.686
=0.29

Merus Labs International's Asset Turnover for the quarter that ended in Mar. 2017 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Mar. 2017 )/( (Total Assets (Q: Dec. 2016 )+Total Assets (Q: Mar. 2017 ))/ count )
=16.918/( (270.517+261.132)/ 2 )
=16.918/265.8245
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Merus Labs International  (NAS:MSLI) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Merus Labs International's annulized ROE % for the quarter that ended in Mar. 2017 is

ROE %**(Q: Mar. 2017 )
=Net Income/Total Stockholders Equity
=-3.504/140.4625
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-3.504 / 67.672)*(67.672 / 265.8245)*(265.8245/ 140.4625)
=Net Margin %*Asset Turnover*Equity Multiplier
=-5.18 %*0.2546*1.8925
=ROA %*Equity Multiplier
=-1.32 %*1.8925
=-2.49 %

Note: The Net Income data used here is four times the quarterly (Mar. 2017) net income data. The Revenue data used here is four times the quarterly (Mar. 2017) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Merus Labs International's annulized ROA % for the quarter that ended in Mar. 2017 is

ROA %(Q: Mar. 2017 )
=Net Income/Total Assets
=-3.504/265.8245
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-3.504 / 67.672)*(67.672 / 265.8245)
=Net Margin %*Asset Turnover
=-5.18 %*0.2546
=-1.32 %

Note: The Net Income data used here is four times the quarterly (Mar. 2017) net income data. The Revenue data used here is four times the quarterly (Mar. 2017) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Merus Labs International Asset Turnover Related Terms

Thank you for viewing the detailed overview of Merus Labs International's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Merus Labs International (Merus Labs International) Business Description

Traded in Other Exchanges
N/A
Address
Merus Labs International Inc was incorporated on October 1, 2012 in British Columbia. The Company is a specialty pharmaceutical company. It acquires prescription medicines in various categories which include on patent but at maturity stage of product life cycle; branded generics; under promoted products; Niche market pharmaceuticals; and products with annual sales below critical threshold for large pharma. The Company competes with multinational pharmaceutical development corporations to small, single product companies that may limit their activities to a particular therapeutic area or region or territory.

Merus Labs International (Merus Labs International) Headlines